A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator
Panzara, Michael
Awardee Organization
Awardee State
Contact PI Country
Project Detail
FY Overall Cost
$1,190,392
Funding Organization
Agency/Funding Organization
Funding Organization Country